Medicare Enrolled

Dr. Muhammad Khan, M.D.

Pain Medicine · Round Rock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7215 WYOMING SPGS, Round Rock, TX 78681
5123881190
In practice since 2007 (18 years)
NPI: 1538348438 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Muhammad Khan is a pain medicine in Round Rock, TX, with 18 years in practice. Based on federal Medicare data, Dr. Khan performed 6,790 Medicare services across 1,640 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $2,844 from 36 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 8% volume in TX$ $2,844 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,790
Medicare services
Top 8% in TX for pain medicine
1,640
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~377 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)3,976$0$10
Office visit, established patient (30-39 min)834$87$463
Office visit, established patient (20-29 min)731$60$313
Contrast dye for imaging (iodine-based)159$0$75
Contrast dye for imaging, lower concentration157$0$75
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level145$210$1,096
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level103$84$381
Injection of substance into lower spine canal using imaging guidance74$192$2,505
New patient office visit (45-59 min)73$125$715
Injection of lower or sacral spine facet joint using imaging guidance, single level72$126$749
Injection of lower or sacral spine facet joint using imaging guidance, second level72$66$377
Joint injection, major joint61$52$320
New patient office visit (30-44 min)57$82$463
Injection of substance into middle or upper spine canal using imaging guidance50$193$2,548
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint42$321$1,837
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint42$180$758
Injection of upper or middle spine facet joint using imaging guidance, single level35$142$831
Injection of upper or middle spine facet joint using imaging guidance, second level35$72$411
Office visit, established patient (10-19 min)28$41$186
Fluoroscopic guidance for needle placement26$89$432
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance18$136$816
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,844
Total received (2018-2024)
Avg $406/year across 7 years
Bottom 48% in TX for pain medicine
36
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,828 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$632
2023
$432
2022
$492
2021
$133
2020
$54
2019
$546
2018
$555

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$974
Abbott Laboratories
$462
Nevro Corp.
$169
Vertos Medical, Inc.
$154
Medtronic, Inc.
$107
SI-BONE, Inc.
$95
DePuy Synthes Sales Inc.
$72
ABBVIE INC.
$72
BOSTON SCIENTIFIC CORPORATION
$66
Amgen Inc.
$64
Collegium Pharmaceutical, Inc.
$45
Medtronic USA, Inc.
$38
FUJIFILM SonoSite, Inc.
$38
Saluda Medical Americas, Inc.
$37
AbbVie Inc.
$37
BioDelivery Sciences International, Inc.
$36
Curonix LLC
$35
Pernix Therapeutics Holdings, Inc.
$32
Nuvectra Corporation
$30
Sentynl Therapeutics, Inc.
$28
SI-BONE, INC.
$27
Ferring Pharmaceuticals Inc.
$23
Kowa Pharmaceuticals America, Inc.
$20
PAINTEQ LLC
$19
Insmed, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$16
Purdue Pharma L.P.
$15
Orthogenrx Inc.
$15
Merck Sharp & Dohme LLC
$14
Merck Sharp & Dohme Corporation
$14
Bioventus LLC
$14
Arbor Pharmaceuticals, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Novartis Pharmaceuticals Corporation
$12
Daiichi Sankyo Inc.
$11
Forte Bio-Pharma LLC
$10
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
AVYCAZ · Aimovig · Algovita · Arikayce · BUNAVAIL 2.1 mg 30-count box · CONFIDENCE · CoverEdge 32 · DALVANCE · DIFICID · Durolane · EUFLEXXA · Edge Ultrasound System · Evoke · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GenVisc 850 · General - Pain Management · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Levorphanol · MONOVISC · Morphabond ER · Nalocet · Nucynta · ORTHOVISC · Octrode SCS Leads · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · SPECTRA WAVEWRITER · SYMPROIC · SYNCHROMED · SYNVISC-ONE · Seglentis · Senza Spinal Cord Stimulation System · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $42 per 100 Medicare services performed
Looking for a pain medicine in Round Rock?
Compare pain medicines in the Round Rock area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
26
Per 100K population
4.0
County median income
$108,309
Nearest hospital
ROUND ROCK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Khan performed 3,976 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $2,844 from 36 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other pain medicines in Round Rock?
Dr. Khan's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →